OOIR: Observatory of International Research

Papers

(The TQCC of Gut Pathogens is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Systemic IgG responses to glycosylated mucinase YghJ after experimental enterotoxigenic Escherichia coli infection	165
Comprehensive evaluation and progress of colorectal cancer screening methods	60
Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine	55
A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia	51
Novel indole-based sulfonate and sulfamate derivatives as potent and selective urease inhibitors targeting Helicobacter pylori: a promising therapeutic strategy	50
A case–control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race	49
Invasion of intestinal cells by Staphylococcus warneri, a member of the human gut microbiota	44
The emerging role of neutrophilic extracellular traps in intestinal disease	44
A monoclonal antibody collection for C. difficile typing ?	40
Analysis of antimicrobial resistance patterns and genetic mutations in Helicobacter pylori from West Bengal, India depicting escalating clarithromycin and high levofloxacin resistance	39
Enhanced pathogen detection and gut microbiome alterations in pyogenic liver abscess: insights from next-generation sequencing	38
Dietary patterns drive loss of fiber-foraging species in the celiac disease patients gut microbiota compared to first-degree relatives	38
Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies	37
Stunting is associated with persistent and transferable alterations in the gut microbiome	36
Equol: a metabolite of gut microbiota with potential antitumor effects	34
Elucidating antibiofilm as well as photocatalytic disinfection potential of green synthesized nanosilver against multi-drug-resistant bacteria and its photodegradation ability of cationic dyes	29
Sodium butyrate augments the antibacterial activity of tetracycline against clinical isolates of multidrug-resistant Vibrio cholerae	29
Intestinal metabolites predict treatment resistance of patients with depression and anxiety	24
Characteristics of ESBL-positive Klebsiella pneumoniae isolated from paired children with and without diarrhea	24
Tropical sprue: a narrative review of a neglected malabsorption syndrome	20
Genomic diversity, antibiotic resistance, and maturation‑dependent adhesion of F18 enterotoxigenic Escherichia coli strains in porcine intestinal cells	20
Profile of intestinal fungal microbiota in acute pancreatitis patients and healthy individuals	20
Longitudinal dynamics of gut microbiota and mycobiota in pneumonia-derived sepsis: evidence of taxonomic stability and trans-kingdom network reorganization	20
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease	19
Patients with inflammatory bowel disease exhibit increased susceptibility to HCoV-NL63	19

A systematic review and meta-analysis of protozoan parasite infections among patients with mental health disorders: an overlooked phenomenon	18
Tripartite interplay: immune reconstitution dynamics in AIDS, gut microbiota, and Helicobacter pylori infection: current advances and therapeutic prospects	18
Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets	18
Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer	18
Impact of invasive infections on clinical outcomes in acute pancreatitis: early predictive factors and implications for prophylactic anti-infective therapy	17
Gut microbiome changes in people with diabetic retinopathy in India. DRMS-India report # 1: operational protocol and trends from first 100 participants	17
Risk stratification of spontaneous bacterial peritonitis recurrence: integrating acute kidney injury, biomarkers, composite scores, and machine learning models	16
Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli	16
Pathogenetic detection, retrospective and pathogenicity analysis of a fatal case of Vibrio vulnificus in Shenzhen, China	16
Shigella flexneri and Shigella sonnei among children under five in Kenya’s urban informal settlement	16
Genomes of Vibrio metoecus co-isolated with Vibrio cholerae extend our understanding of differences between these closely related species	15
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?	15
Contrasting the gut microbiome in Colombian patients with diarrhea: a comparative metagenomic study in hospitalization and emergency room services	14
Epidemiological, clinical, and molecular characteristics of coxsackievirus A2 infections during a herpangina outbreak in children on an Island in Eastern China in 2024: a surveillance-based study	14
Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation	14
Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load	14
Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	14
Assessing whether rectal swabs reflect appendiceal microbiota profiles in acute appendicitis: a 16S rRNA-based comparative study	14
Prevalence of intestinal parasites and Helicobacter pylori coinfection, and contributing factors among patients with gastrointestinal manifestations at Addis Zemen primary hospital, Northwest Ethiopia	13
Antimicrobial growth promoters approved in food-producing animals in South Africa induce shiga toxin-converting bacteriophages from Escherichia coli O157:H7.	13
Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report	13
Risk factors and clinical outcomes associated with multiple as opposed to single pathogens detected on the gastrointestinal disease polymerase chain reaction assay	13
Gram-negative gut colonization in children newly diagnosed with malignancy: microbiology, antimicrobial resistance pattern, and clinical implications	13
Tissue-specific transcriptomic adaptation in three strains of chickens during coinfections with parasites	12
High resolution melting real-time PCR for genotyping of Giardia lamblia assemblages A and B regardless of parasite load	12
Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982–2024) and food safety criteria	12
Modulatory role of Akkermansia muciniphila in cancer pathophysiology: a systematic review and meta-analysis of preclinical studies	12
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population	12
Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer	12
Survival implications of the age-associated tumor and normal adjacent tissue microbiome among colorectal cancer patients	11
Machine learning approach and internet of things technologies to unravel the complex interaction between microbiome-metabolome in inflammatory bowel disease: a new frontier in precision medicine	11
The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection	11
Metagenomics: a new frontier for routine pathology testing of gastrointestinal pathogens	11
A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis	11
Cross-country multi-modal evidence links Aspergillus to biliary atresia	11
Determinants of Campylobacter species diversity in infants and association with family members, livestock, and household environments in rural Eastern Ethiopia	11
Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks	11
Bacteremia from streptococcus constellatus revealing a gastrointestinal stromal tumor	10
Gut microbiome-based strategies for HIV prevention and therapy, current challenges and future prospects	10
Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage	10
Nasopharyngeal viral infection as a source of elevated fecal calprotectin: a diagnostic pitfall in intestinal inflammation	10
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial	10
Brevilin A reverses colitis of inflammatory bowel disease via modulation of TNF-α signaling and microbiome dysregulation	10
Salmonella prevalence and serovar distribution in reptiles: a systematic review and meta-analysis	10
Targeting autophagy and programmed cell death in neurological diseases via probiotic intervention	10
Genomic insights into zoonotic transmission and antimicrobial resistance in Campylobacter jejuni from farm to fork: a one health perspective	10
Etiology of diarrheal hospitalizations following rotavirus vaccine implementation and association of enteric pathogens with malnutrition among under-five children in India	10
Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens	10
Development of the gut microbiota during early life in premature and term infants	9
Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case–control study in childhood stunting in Pidie, Aceh, Indonesia	9

The association between Helicobacter pylori and osteoporosis: the mediating effect of inflammation	9
Correction: Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	9
miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis	9
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota	9
Genetic evolution and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in and outside China with reference to a wild type virulent genotype CHYJ130330 reported from Guangdo	9
Gut microbiota and intestinal polyps: a systematic review and meta-analysis based on 16S rRNA gene sequencing	9
Gut microbiota signatures and predictive model of KPS in advanced colorectal cancer patients	9
Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets	9
Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials	9
Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit	9
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India	8
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes	8
Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn’s disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis	8
Whole-genome sequencing analyses and antibiotic resistance situation of 48 Helicobacter pylori strains isolated in Zhejiang, China	8
Genotyping and molecular profiling of intestinal microsporidiosis and cryptosporidiosis in HIV-infected patients in Alborz Province, Iran	8
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients	8
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma	8
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis	8
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis	8
Helicobacter pylori infection is associated with an increased risk of chronic obstructive pulmonary disease and asthma	8
Lactococcus cremoris decreases virulence‑associated properties, and modifies the protein profile of foodborne pathogen Campylobacter jejuni in biofilm	8